2000
DOI: 10.1006/bbrc.2000.2887
|View full text |Cite
|
Sign up to set email alerts
|

Characterization of the Tyrosine Kinase Tnk1 and Its Binding with Phospholipase C-γ1

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
21
0

Year Published

2005
2005
2021
2021

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 16 publications
(21 citation statements)
references
References 32 publications
0
21
0
Order By: Relevance
“…In conclusion, TNK1 is constitutively phosphorylated/active upon expression and therefore likely to be regulated by expression. TNK1 protein is reportedly expressed in fetal blood cells and in some tumor cell lines including prostate cancer cells (Felschow et al, 2000). We found very little TNK1 expression in two prostate cancer cell lines, LnCap and PC3.…”
Section: Tnk1 Is Constitutively Active Upon Expressionmentioning
confidence: 58%
See 2 more Smart Citations
“…In conclusion, TNK1 is constitutively phosphorylated/active upon expression and therefore likely to be regulated by expression. TNK1 protein is reportedly expressed in fetal blood cells and in some tumor cell lines including prostate cancer cells (Felschow et al, 2000). We found very little TNK1 expression in two prostate cancer cell lines, LnCap and PC3.…”
Section: Tnk1 Is Constitutively Active Upon Expressionmentioning
confidence: 58%
“…Messenger RNA (mRNA) expression of TNK1 is detectable in B-cell progenitors, fetal tissues, leukemia and tumor cell lines (Hoehn et al, 1996). TNK1 protein is expressed in fetal blood cells, but not in other hematopoietic tissues (Felschow et al, 2000). Our data show that expression of TNK1 is epigenetically silenced in certain tumor cells.…”
Section: Introductionmentioning
confidence: 69%
See 1 more Smart Citation
“…2, 3). Whereas the 47-kDa Kos1 is ubiquitously expressed in mouse tissues, as well as human fetal blood and leukemia cell lines, the predicted 72-kDa Tnk1 can be detected in human fetal blood, but not in mouse cells, by Western blotting (3,33). A point mutation in Tnk1/Kos1 that inactivates the catalytic activity has been shown to abolish its growth inhibitory properties, indicating that the tyrosine kinase activity is required for Tnk1/Kos1 function (2,3).…”
Section: Discussionmentioning
confidence: 99%
“…Consistent with this analysis, direct binding of PLCγ1-SH3 to peptides from TNK1 and dynamin representing putative recognition sites has been demonstrated. 20,37 Other XPXXPXR sequences in c-Cbl and SOS1 (group B), while lacking proline at the position following the compass arginine, may nevertheless exhibit significant affinity for PLCγ1-SH3, since elimination of the corresponding proline in SLP-76 did not abolish binding (Table 1). Although both CAIR-1/BAG-3 and SAM 68 interact with PLCγ1-SH3, 19,38 neither contains a class II motif (group C), suggesting that PLCγ1-SH3 may also recognize other motifs, as recently demonstrated for Gads-SH3.…”
Section: Interaction Of Plcγ1-sh3 With Other Signaling Proteinsmentioning
confidence: 99%